An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2019-01-07 / Int. J. Cancer 2019 Jun;144(11):2867-2879A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers
/in Dendritic Cells, International Publications /von 2019-01-01 / Methods Mol. Biol. 2019;1884:317-333Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2019-01-01 / Klin Onkol 2019;32(1):70-74Immunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2019-01-01 / Crit Rev Immunol 2019;39(3):211-221Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-12-05 / Acta Neuropathol Commun 2018 12;6(1):135Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-12-05 / Blood Rev. 2019 03;34:67-83Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2018-12-05 / Front Immunol 2018;9:2759Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
/in Dendritic Cells, Gastric Cancer, International Publications /von 2018-12-04 / Clin. Cancer Res. 2019 Mar;25(5):1494-1504Current State of Dendritic Cell-Based Immunotherapy: Opportunities for Antigen Loading of Different DC Subsets?
/in Dendritic Cells, International Publications /von 2018-12-03 / Front Immunol 2018;9:2804
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de